Patents by Inventor Marina LAURENT

Marina LAURENT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240299549
    Abstract: An aqueous composition, containing indocyanine green (a), and a compound (b) chosen from ascorbic acid, its salts, and mixtures thereof. A weight ratio of compound (b) to indocyanine green (a) ranges from 0.15 to 15 and a concentration of the indocyanine green (a) in the aqueous composition is between 0.1 and 30 mg/ml.
    Type: Application
    Filed: March 14, 2022
    Publication date: September 12, 2024
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Marina LAURENT, Babak SAYAH, Nicolas LOPEZ
  • Publication number: 20240165275
    Abstract: A composition, containing 10 to 70% of indocyanine green, 0.1 to 15% of ethylenediaminetetraacetic acid (EDTA) and/or one or more salts thereof, 1 to 20% of histidine, and 20 to 80% of sodium chloride. The percentages are expressed by weight relative to a total weight of the indocyanine green, EDTA, histidine, and sodium chloride.
    Type: Application
    Filed: March 14, 2022
    Publication date: May 23, 2024
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Marina LAURENT, Babak SAYAH, Nicolas LOPEZ
  • Publication number: 20240156991
    Abstract: A composition, containing indocyanine green (a), and histidine (b). A weight ratio of histidine (b)/indocyanine green (a) is greater than 0.05. A kit for preparing the composition, containing in separate compartments the indocyanine green (a), and an aqueous solution including the histidine (b). The composition is a medicament or a diagnostic agent.
    Type: Application
    Filed: March 14, 2022
    Publication date: May 16, 2024
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Marina LAURENT, Babak SAYAH, Florian COURIVAUD, Nicolas LOPEZ
  • Patent number: 11891367
    Abstract: Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide, the method resulting in a high purity while being very simple to implement and producing high yields. The method uses phenothiazine as a starting material and includes the following steps: a) treating phenothiazine with diiodine, b) treating the reaction medium directly obtained from step a) with dimethylamine.
    Type: Grant
    Filed: June 29, 2021
    Date of Patent: February 6, 2024
    Assignee: PROVEPHARM LIFE SOLUTIONS
    Inventors: Michel Feraud, Babak Sayah, Stéphane Queru, Marina Laurent
  • Publication number: 20210323937
    Abstract: Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide, the method resulting in a high purity while being very simple to implement and producing high yields. The method uses phenothiazine as a starting material and includes the following steps: a) treating phenothiazine with diiodine, b) treating the reaction medium directly obtained from step a) with dimethylamine.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 21, 2021
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Michel FERAUD, Babak SAYAH, Stéphane QUERU, Marina LAURENT
  • Patent number: 11078169
    Abstract: Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide, the method resulting in a high purity while being very simple to implement and producing high yields. The method uses phenothiazine as a starting material and includes the following steps: a) treating phenothiazine with diiodine, b) treating the reaction medium directly obtained from step a) with dimethylamine.
    Type: Grant
    Filed: February 16, 2018
    Date of Patent: August 3, 2021
    Assignee: PROVEPHARM LIFE SOLUTIONS
    Inventors: Michel Feraud, Babak Sayah, Stéphane Queru, Marina Laurent
  • Publication number: 20200010438
    Abstract: Method for preparing 3,7-bis(dimethylamino)phenothiazin-5-ylium iodide, the method resulting in a high purity while being very simple to implement and producing high yields. The method uses phenothiazine as a starting material and includes the following steps: a) treating phenothiazine with diiodine, b) treating the reaction medium directly obtained from step a) with dimethylamine.
    Type: Application
    Filed: February 16, 2018
    Publication date: January 9, 2020
    Applicant: PROVEPHARM LIFE SOLUTIONS
    Inventors: Michel FERAUD, Babak SAYAH, Stéphane QUERU, Marina LAURENT